FDA Evaluation Of Risk Management Plans And “Tools” Needed, PhRMA Says
Executive Summary
FDA should undertake a review of all current and past risk management plans and "tools" to document their effectiveness, PhRMA says
You may also be interested in...
Risk Management Guidance Suggests Advisory Cmte Review For RiskMAPs
FDA recommends that advisory committees weigh in on whether a risk minimization action plan is appropriate for a particular drug
Risk Management Guidance Suggests Advisory Cmte Review For RiskMAPs
FDA recommends that advisory committees weigh in on whether a risk minimization action plan is appropriate for a particular drug
FDA Risk Management Plan: Four Levels, From Labeling To Restricted Access
FDA is proposing four levels of risk management programs for prescription drugs and biologics in a "Risk Management Programs" draft 1concept paper released March 6